U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07312513) titled 'Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft(R) Duo With Debrisoft(R) Pad in the Debridement of Wounds' on Dec. 17, 2025.

Brief Summary: The aim of this post market clinical follow up (PMCF) study is to confirm the performance of Debrisoft(R) Duo, to collect safety data regarding expected adverse events and to detect potential unexpected adverse events associated with the use of Debrisoft(R) Duo within the certified indications and under the conditions of routine use.

Study Start Date: May 09, 2025

Study Type: INTERVENTIONAL

Condition: Diabetic Ulcers Arterial Ulcers Venous Ulc...